Pharmaniaga incurs RM178.6mil net loss in fourth quarter


Pharmaniaga said the higher revenue was mainly attributable to stronger demand from the concession, non-concession and Indonesia businesses.

PETALING JAYA: Pharmaniaga Bhd slid into a net loss of RM178.6mil for the fourth quarter ended Dec 31,2019, from a net profit of RM4.4mil in the corresponding quarter in the preceding year.

For the quarter in review, the pharmaceutical company saw its revenue grow 20% to RM715.7mil from RM596.6mil.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , loss , fourth quarter , Indonesian , business , revenue ,

Next In Business News

Capital A expect to exit PN17 status by year-end
Felda proposes establishing national taskforce to develop oil palm carbon framework
Bursa Malaysia remains lower at midday, KLCI down 0.54%
Geohan secures RM59mil contracts for Penang LRT project
MUI Properties to buy Ijok land for RM605mil
Geohan sets sights on Singapore to drive regional growth
DRB-Hicom shares up on revised US$110.62mil purchase price for Spirit MY
AirAsia X eyes second-tier cities and broader Europe-Central Asia connectivity next year
Japan's Nikkei skids in subdued Asia as bets of rate hike grow
Oil prices head for 2% weekly gain as Fed hopes boost market, Venezuela tensions loom

Others Also Read